Literature DB >> 23557591

Effects of prediabetes and diabetes on left ventricular and coronary microvascular functions.

Dogan Erdogan1, Habil Yucel, Bayram Ali Uysal, Ismail Hakkı Ersoy, Atilla Icli, Salaheddin Akcay, Akif Arslan, Fatih Aksoy, Mehmet Ozaydin, M Numan Tamer.   

Abstract

BACKGROUND: Coronary flow reserve (CFR) provides independent prognostic information in diabetic patients with known or suspected coronary artery disease. However, there have been no substantial data to evaluate CFR in prediabetics. Accordingly, we aimed to evaluate CFR in subjects with prediabetes using second harmonic transthoracic Doppler echocardiography. METHODS AND
RESULTS: We measured CFR of 65 subjects with prediabetes, 45 patients with overt type 2 diabetes, and 43 sex and age matched normoglycemic healthy subjects with normal glucose tolerance. Ages, gender, existence of hypertension or hypercholesterolemia, smoking status were similar among the groups. CFR was significantly lower in diabetics (2.15 ± 0.39) than in prediabetics (2.39 ± 0.45) and controls (2.75 ± 0.35); in addition, it was significantly lower in prediabetics than controls. Only 2 (5%) of control subjects had abnormal CFR (<2) but 11 (17%) prediabetic subjects and 19 (42%) diabetic patients had abnormal CFR. We found that only age (β=-0.31, P<0.01) and presence of the diabetes (β=-0.57, P<0.01) were significant predictors of lower CFR in a multivariable model that adjusted for other variables. CFR was significantly and inversely correlated with age (r=-0.15, P=0.04), fasting glucose level (r=-0.27, P=0.001), postprandial glucose level (r=0.43, P<0.001), hemoglobin A1C level (r=-0.34, P<0.001), LDL cholesterol level (r=0.22, P=0.009), mitral A velocity (r=-0.27, P=0.001) and Tei index (r=-0.19, P=0.02), whereas mitral E/A ratio, mitral Em (r=0.18, P=0.02), mitral Em/Am ratio (r=0.23, P=0.004) were significantly and positively correlated with CFR.
CONCLUSION: CFR is impaired in subjects with prediabetics, but this impairment is not as severe as that in diabetics.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADA; American Diabetes Association; BMI; BP; CAD; CFR; CV; Coronary flow reserve; DM; DPP; DT; DTI; Diabetes; Diabetes Prevention Program; Doppler tissue-imaging; Echocardiography; FPG; Hs-CRP; IFG; IGT; IVRT; LAD; LV; LVMI; OGTT; Prediabetes; RAAS; TTDE; blood pressure; body-mass index; cardiovascular; coronary artery disease; coronary flow reserve; deceleration time; diabetes mellitus; fasting plasma glucose; high sensitivity C reactive protein; impaired fasting glucose; impaired glucose tolerance; isovolumic relaxation time; left anterior descending; left ventricular; left ventricular mass index; oral glucose tolerance test; renin angiotensin aldosterone system; transthoracic Doppler echocardiography

Mesh:

Substances:

Year:  2013        PMID: 23557591     DOI: 10.1016/j.metabol.2013.02.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with Type 2 diabetes.

Authors:  Mary E Lott; Julia E Slocomb; Zhaohui Gao; Robert A Gabbay; David Quillen; Thomas W Gardner; Kerstin Bettermann
Journal:  Microvasc Res       Date:  2015-05-20       Impact factor: 3.514

2.  What do primary care prediabetes patients need? A baseline assessment of patients engaging in a technology-enhanced lifestyle intervention.

Authors:  Jennifer M Kolb; Nicole R Kitos; Ambili Ramachandran; Jenny J Lin; Devin M Mann
Journal:  J Bioinform Diabetes       Date:  2014-02-02

3.  New research developments and insights from Metabolism.

Authors:  Olivia M Farr; Michelle Camp; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-12-17       Impact factor: 8.694

4.  Investigating microRNAs in diabetic cardiomyopathy as tools for early detection and therapeutics.

Authors:  Priyanka Mathur; Vibha Rani
Journal:  Mol Cell Biochem       Date:  2022-07-02       Impact factor: 3.396

5.  Cardiovascular sexual dimorphism in a diet-induced type 2 diabetes rodent model, the Nile rat (Arvicanthis niloticus).

Authors:  Jillian Schneider; Sharee Kuny; Donna Beker; Yves Sauvé; Hélène Lemieux
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

Review 6.  The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.

Authors:  Giacomo Zoppini; Corinna Bergamini; Alessandro Mantovani; Marco Dauriz; Giovanni Targher; Andrea Rossi; Enzo Bonora
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

7.  HuR/Cx40 downregulation causes coronary microvascular dysfunction in type 2 diabetes.

Authors:  Rui Si; Jody Tori O Cabrera; Atsumi Tsuji-Hosokawa; Rui Guo; Makiko Watanabe; Lei Gao; Yun Sok Lee; Jae-Su Moon; Brian T Scott; Jian Wang; Anthony W Ashton; Jaladanki N Rao; Jian-Ying Wang; Jason X-J Yuan; Ayako Makino
Journal:  JCI Insight       Date:  2021-11-08

8.  Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes.

Authors:  Rui Si; Qian Zhang; Atsumi Tsuji-Hosokawa; Makiko Watanabe; Conor Willson; Ning Lai; Jian Wang; Anzhi Dai; Brian T Scott; Wolfgang H Dillmann; Jason X-J Yuan; Ayako Makino
Journal:  Cardiovasc Res       Date:  2020-05-01       Impact factor: 10.787

9.  Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease.

Authors:  Takayuki Kawata; Masao Daimon; Rei Hasegawa; Tomohiko Toyoda; Tai Sekine; Toshiharu Himi; Daigaku Uchida; Sakiko Miyazaki; Kuniaki Hirose; Ryoko Ichikawa; Masaki Maruyama; Hiromasa Suzuki; Hiroyuki Daida
Journal:  Cardiovasc Diabetol       Date:  2013-08-27       Impact factor: 9.951

Review 10.  Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions.

Authors:  Li-Ming Gan; Johannes Wikström; Regina Fritsche-Danielson
Journal:  J Cardiovasc Transl Res       Date:  2013-07-23       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.